In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), ITUS Corp (NASDAQ:ITUS) reported that Kumar Amit has picked up 900,852 of common stock as of 2017-06-22.
The acquisition brings the aggregate amount owned by Kumar Amit to a total of 900,852 representing a 5.67% stake in the company.
For those not familiar with the company, ITUS Corporation is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek cancer detection platform measures a patient’s immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream. Instead of seeking to alter or boost the body’s immune system and its ability to destroy cancer cells, the Company has developed techniques and protocols for measuring the subtle immunological changes that occur in the blood stream during tumor development. Through its protocols, the Company has detected the biomarkers in the peripheral blood of biopsy verified cancer patients, and in distinguishing the blood of healthy patients from the blood of cancer patients.
A glance at ITUS Corp (NASDAQ:ITUS)’s key stats reveals a current market capitalization of $12.19 Million based on $15.12 Million shares outstanding and a price at last close of $0.825 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-06-05, Kumar picked up 10,000 at a purchase price of $0.90. This brings their total holding to 124,408 as of the date of the filing.
On the sell side, the most recent transaction saw Titterton unload 210,000 shares at a sale price of $3.10. This brings their total holding to 287,437.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an ITUS Corp (NASDAQ:ITUS) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.